This is a news story, published by MediHelp – Medical journal & More, that relates primarily to CDC news.
For more disease research news, you can click here:
more disease research newsFor more news from MediHelp – Medical journal & More, you can click here:
more news from MediHelp – Medical journal & MoreOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
doxycycline. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest postexposure prophylaxis news, prophylaxis news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
STI preventionMediHelp – Medical journal & More
•83% Informative
The CDC has issued new guidelines on using doxycycline as postexposure prophylaxis (doxy PEP ) to prevent bacterial sexually transmitted infections (STIs) These recommendations, released in 2024 , specifically target gay, bisexual, and other men who have sex with men ( MSM ) as well as transgender women ( TGW ) who are at heightened risk for STIs.
VR Score
89
Informative language
93
Neutral language
54
Article tone
formal
Language
English
Language complexity
67
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
1
Source diversity
1
Affiliate links
no affiliate links